Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials by Viney, Nicholas J, BSc, van Capelleveen, Julian C, MD, Geary, Richard S, PhD, Xia, Shuting, MS, Tami, Joseph A, PharmD, Yu, Rosie Z, PhD, Marcovina, Santica M, Prof, Hughes, Steven G, MD, Graham, Mark J, MS, Crooke, Rosanne M, PhD, Crooke, Stanley T, MD, Witztum, Joseph L, Prof, Stroes, Erik S, Prof, Tsimikas, Sotirios, Prof

Get full text

Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study by Tsimikas, Sotirios, Prof, Viney, Nicholas J, BSc, Hughes, Steven G, MBBS, Singleton, Walter, MD, Graham, Mark J, MS, Baker, Brenda F, PhD, Burkey, Jennifer L, PhD, Yang, Qingqing, MS, Marcovina, Santica M, Prof, Geary, Richard S, PhD, Crooke, Rosanne M, PhD, Witztum, Joseph L, Prof

Get full text

Antisense Oligonucleotide Lowers Plasma Levels of Apolipoprotein (a) and Lipoprotein (a) in Transgenic Mice by Merki, Esther, PhD, Graham, Mark, BS, Taleb, Adam, MD, Leibundgut, Gregor, MD, Yang, Xiaohong, BS, Miller, Elizabeth R., BS, Fu, Wuxia, MS, Mullick, Adam E., PhD, Lee, Richard, PhD, Willeit, Peter, MD, Crooke, Rosanne M., PhD, Witztum, Joseph L., MD, Tsimikas, Sotirios, MD

Get full text

Antisense Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes by Digenio, Andres, MD, PhD, Dunbar, Richard, MD, Alexander, Veronica, PhD, Hompesch, Marcus, MD, Morrow, Linda, MD, Lee, Richard, PhD, Graham, Mark, MS, Hughes, Steven, MB, BS, Yu, Rosie, PhD, Singleton, Walter, MD, Baker, Brenda, PhD, Bhanot, Sanjay, MD, PhD, Crooke, Rosanne, PhD

Get full text